This is a regulatory disclosure submitted to the National Stock Exchange of India Limited and BSE Limited, intimating them of the company's upcoming Annual General Meeting and related corporate actions.

Key Dates and Corporate Actions

  • The 22nd AGM will be held on Friday, July 31, 2026, at 3:00 P.M. (IST). The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means.
  • The company has fixed Friday, July 10, 2026, as the "Record Date" for determining eligibility for the final dividend.
  • A Final Dividend of ₹0.45 per equity share (face value of ₹1 each), representing a 45% payout for the financial year 2025-26, has been recommended by the Board of Directors. This dividend is subject to approval by shareholders at the AGM.
  • If approved, the dividend will be paid within 30 days of the date of the AGM.

Eligibility for Dividend

The dividend will be paid to:

  • Beneficial owners whose names appear in the records of National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) as of the close of business on July 10, 2026, for shares held in electronic form.
  • Shareholders whose names appear in the company's Register of Members as of the close of business on July 10, 2026, for shares held in physical form.

E-Voting and Shareholder Communication

  • The cut-off date for determining shareholders eligible to vote at the AGM is Friday, July 24, 2026.
  • The remote e-voting period will be from 9:00 A.M. (IST) on Tuesday, July 28, 2026, to 5:00 P.M. (IST) on Thursday, July 30, 2026.
  • The Annual Report for FY 2025-26 and the Notice of the 22nd AGM will be sent electronically to all shareholders whose email addresses are registered with the company, its Registrar and Transfer Agent (RTA), or their Depository Participants (DPs).
  • These documents will also be available on the company's website at www.artemishospitals.com.
  • For shareholders without a registered email address, the company will send a physical letter providing a web link to access the Annual Report, in accordance with Regulation 36(1)(b) of the SEBI Listing Regulations.

Signatory and Submission